Could ginseng-based medicines be better than nitrates in treating ischemic heart disease? A systematic review and meta-analysis of randomized controlled trials

Complementary Therapies in Medicine

Volumn 20, Issue 3, 2012, Pages 155-166

  Jia, Yongliang ^a,b   Zhang, Shikai ^a,b   Huang, Fangyi ^a   Leung, Siu wai ^a,b,c  

^a UNIVERSITY OF MACAU   (Macao)

^b University of Macau   (Macao)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Angina pectoris; Ginseng; Ischemic heart disease; Meta analysis; Nitrates; Randomized controlled trials; Systematic review

Indexed keywords

HERBACEOUS AGENT; NITRATE;

ANGINA PECTORIS; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; ELECTROCARDIOGRAPHY; GINSENG; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 84859702971     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2011.12.002     Document Type: Review

References (48)

1. Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation 1979; 3:607-9.
2. Yue P.Y.K., Mak N.K., Cheng Y.K., Leung K.W., Ng T.B., Fan D.T.P., et al. Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chinese Medicine 2007, 2:6.
3. Lala P.K., Chakraborty C. Role of nitric oxide in carcinogenesis and tumor progression. The Lancet Oncology 2001, 2:149-156.
4. Oemar B.S., Tschiudi M.R., Godoy N., Brovkovich V., Malinski T., Luscher T.F. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998, 97:2493-2498.
5. Dulak J., Jozkowicz A., Dembinska-Kiec A., Guevara I., Zdzienicka A., Zmudzinska-Grochot D., et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2000, 20:659-666.
6. The school of Basic Medical Sciences Norman Bethune University of Medical Science. Summary of Clinical Observations of Ginseng Treating 300 Ischemic Heart Disease Patients. U.S. Research Reports Inc., Research Report No. 204.
7. Wang H., Peng D., Xie J. Ginseng leaf-stem: bioactive constituents and pharmacological functions. Chinese Medicine 2009, 4:20.
8. Chen J., Chen T. Chinese medical herbology and pharmacology 2004, Art of Medicine Press, Chapter 17, Section 1, p. 835-40.
9. Ginseng (American ginseng, Asian ginseng, Chinese ginseng, Korean red ginseng, Panax ginseng: Panax spp. including P. ginseng C.C. Meyer and P. quinquefolius L., excluding Eleutherococcus senticosus). Natural Standard Bottom Line Monograph. Commercial distribution prohibited.
10. Chinese Pharmacopoeia Committee Chinese Pharmacopoeia 2005 edition 2005, Chemical Industry Press.
11. Bao Y.L., Fu A.F., Wu W., Teng L.H. Clinical application review of single ginseng prescription preparation. Research and Information on Traditional Chinese Medicine 2005, 7(8):21-22.
12. Liu Z.L., Liu Z.J., Liu J.P., Yang M., Kwong J. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine 2008, 6(1):76.
13. Wu T., Harrison R.A., Chen X., Ni J., Zhou L., Qiao J., et al. Tongxinluo (Tong xinluoor Tong-xin-luo) capsule for unstable angina pectoris. Cochrane Database Systematic Reviews 2006, (4):CD004474.
14. Jia Y., Huang F., Zhang S., Leung S. Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating anginapectoris? A systematic review of randomized controlled trials. International Journal of Cardiology 2011, 10.1016/j.ijcard.2010.12.073.
15. Gibbons R.J., Abrams J., Chatterjee K., Daley J., Deedwania P.C., Douglas J.S., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003, 107:149-158.
16. Hombach V., Hoher M., Kochs M., Eggeling T., Schmidt A., Hopp H.W., et al. Pathophysiology of unstable angina pectoris-correlations with ischemic angioscopic imaging. European Heart Journal 1998, 9:40-45.
17. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996, 17(1):1-12. 10.1016/0197-2456(95)00134-4.
18. Higgins J.T.P., Green S. Cochrane handbook for systematic reviews of interventions 2008, Wiley Online Library.
19. Wang D., Bakhai A. Clinical trials: a practical guide to design, analysis, and reporting. Remedica 2006.
20. Cook R.J., Sackett D.L. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995, 310:452-454.
21. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometric 1994, 50:1088-1101.
22. Egger M., Smith G.D., Schneider M. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629.
23. Cool R.J., Sackett D.L. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995, 310:452.
24. Bai H.M., Cai X.H. Liver stagnation phlegm type of treating 64 cases of angina pectoris. Shanxi Journal of Traditional Chinese Medicine 2009, 30(2):146-147.
25. Bai Y.S. 34 Patients with ischemic heart disease treated by Shenlong capsule. Chinese Medicine Modern Distance Education of China 2008, 6(11):1367.
26. Gao FJ, Zhang WG. Clinical study on effect of Zhixinkang capsule in treating unstable effort angina and protecting vascular endothelium. Shandong University of Traditional Chinese Medicine 2000; Graduation Thesis of Graduate Student.
27. Guo L.Q., Gao R. Latent ischemic heart disease treated by Shijinmo couplet medicines. China Modern Doctor 2007, 45(20):66-69.
28. Guo T., Yang L. Clinical analysis of 60 patients with ischemic heart disease angina treated by heart-protecting musk pill. Chinese Journal of Medicine Guide 2005, 3(1):59.
29. Li AM, Ding SW. Clinical and experimental research on Ren Shen Jian Xin capsule improving insulin resistance in ischemic heart disease. Shandong University of Traditional Chinese Medicine, 2007; PhD thesis.
30. Li A.M., Zhao J. Ginseng health capsule affected the patients of ischemic heart disease with glucose tolerance insulin resistance. Chinese Journal of Integrated Medicine 2009, 29(9):830-833.
31. Mo Y.Q., Wang Q., Fang X.M., He G.X. Effect of anxin granules on hypersensitive C-reactive protein in ischemic heart disease patients with angina pectoris. Journal of Guangzhou University of Traditional Chinese Medicine 2005, 22(5):341-343.
32. Tan L.H. Clinical analysis of health pulse soup plus-minus compatibility eternal medicine treating ischemic heart disease. Journal of Liaoning College of Traditional Chinese Medicine 2006, 8(3):82.
33. Wang S.Y. 30 Patients with angina pectoris treated by Yiqihuoxue collaterals. Guangming Journal of Chinese Medicine 2008, 23(11):1726-1727.
34. Wang Y.H., Ji H.X., Li X.D. 60 Patients with unstable type ischemic heart disease treated by Tongxinluo capsule. Shanxi Journal of Traditional Chinese Medicine 2003, 23(8):676-678.
35. Xu H.Z., Li J.Y., Su Z.D. Observations on the effects of angina pectoris patients treated by Simiaoyongan soup flavored. Journal of Handan Medical College 2005, 18(1):45-46.
36. Yan C.Y. Clinical observations of angina pectoris patients treated by Tongxinluo capsule. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease 2007, 15(3):217-218.
37. Zhang H. Clinical observed the impact of hemorheology of 30 angina pectoris patients treated by Xuesaitong. Chinese Journal of Integrative Medicine on Cairo-/Cerebrovascular Disease 2005, 3(4):358.
38. Zhang N.Z., Han M.X., Zhou Y.X., Yang W.M. Clinical study on bronchial asthma treated by methods of resolving phlegn, removing blood stasis, lowering the adverse flow of Qi and relieving asthma. Journal of Emergency in Traditional Chinese Medicine 2000, 9(4):141-142.
39. Zhang S.L., Qi D.J. Application of Shengmai Yin in Qi and Yin deficiency ischemic heart disease in chronic heart failure. Jilin Journal of Traditional Chinese Medicine 2009, 29(7):585-586.
40. Zhang Z.X., Yang L. 30 Patients with angina decubitus treated by Wenyang Zhenxin soup. Shanxi Journal of Traditional Chinese Medicine 2004, 25(7):579-580.
41. Zou R., Qin J., Huang R.H. A clinical study on ischemic heart disease ischemia myocardial patients treated by Sini Plus Ginseng soup. Chinese Archives of Traditional Chinese Medicine 2003, 21(5):665-666.
42. Zhong J.D. Pharmacology of traditional chinese medical formulae 2008, Shanghai Science and Technology Press, ISBN: 7532384764, 9787532384761.
43. Gheorghiade M., Bonow R.O. Chronic heart failure in the United States: a manifestation of ischemic artery disease. Circulation 1998, 97:282-289.
44. Wu T.X., Li Y.P., Bian Z.X., Liu G.J., Moher D. Randomized trials published in some Chinese journal: how many are randomized?. Trials 2009, 10:46.
45. Wang G., Mao B., Xiong Z.Y., Fan T., Chen X.D., Wang L., et al. The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China. Clinical Therapeutics 2007, 29(7):1456-1467.
46. Xu L., Li J., Zhang M.M., Ai C.L., Wang L. Chinese authors do need CONSORT: reporting quality assessment for five leading Chinese medical journals. Contemporary Clinical Trials 2008, 29(5):727-731.
47. Zhong Y.Q., Fu J.J., Liu X.M., Diao X., Mao B., Fan T., et al. The reporting quality, scientific rigor, and ethics of randomized placebo-controlled trials of traditional Chinese medicine compound formulations and the differences between Chinese and non-Chinese trials. Current Therapeutic Research 2010, 71(1):30-49.
48. Zhang D.L., Yin P., Freemantle N., Jordan R., Zhong N.S., Cheng K.K. An assessment of the quality of randomized controlled trials conducted in China. Trials 2008, 9:22.